epilepsy: Latest News, Top Stories & Analysis

RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) recently announced its decision to proceed with the Phase 3 RAISE trial of intravenous (IV) ganaxolone for treating refractory status epilepticus (RSE), …

Strategic Combinations

Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council

June 26, 2023June 25, 2023 - by MyChesCo

BERWYN, PA — Virpax®Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced that it has entered into a cooperative research and development agreement (CRADA) with the National Institute of Neurological Disorders and Stroke …